Time to switch from CLSI to EUCAST? a Southeast Asian perspective
Despite the importance of antimicrobial susceptibility testing (AST) to clinical management of infection and to antimicrobial resistance (AMR) surveillance, methodologies and breakpoints of the two most commonly used systems worldwide, CLSI and EUCAST, are far from harmonized. Most laboratories in r...
主要な著者: | Cusack, T, Ashley, E, Ling, C, Roberts, T, Turner, P, Wangrangsimakul, T, Dance, D |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Elsevier
2019
|
類似資料
-
Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance
著者:: Cusack, T-P, 等
出版事項: (2019) -
Effect of Differences in the CLSI and EUCAST Criteria on the Interpretation of Enterobacteriaceae Sensitivity to Carbapenems
著者:: L. A. Kornoukhova, 等
出版事項: (2021-10-01) -
Evaluations of Antifungal Susceptibilities Have to Be According to Reference Guidelines: CLSI and EUCAST
著者:: Ali Korhan Sığ
出版事項: (2022-01-01) -
Estudo comparativo entre as metodologias preconizadas pelo CLSI e pelo EUCAST para avaliação da atividade antifúngica Comparative study of the recommended methodologies by CLSI and EUCAST for activity evaluation antifungal
著者:: Marcos Aurélio Stoppa, 等
出版事項: (2009-01-01) -
Novedades CLSI y EUCAST 2024 sobre detección y uso de antibióticos
著者:: Diego Herrera, 等
出版事項: (2024-08-01)